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Objective: Despite the improvement in ventricular assist device (VAD) therapy in adults
and in adolescents, in infant population only Berlin Heart EXCOR (BHE) is licensed as
long term VAD to bridge children to Heart Transplantation (HTx). Particularly demanding
in terms of morbidity and mortality are smallest patients namely the ones implanted in
the first year of life or with a lower body surface area. This work aims at retrospective
reviewing a single center experience in using BHE in children with a body weight under
10 kg.
Methods: Data of all pediatric patients under 10 kg undergoing BHE implantation in our
institution from March 2002 to March 2016 were retrospectively reviewed.
Results: Of the 30 patients enrolled in the study, 53% were male, 87% were affected
by a dilated cardiomyopathy with an average weight and age at the implantation of 6.75
± 2.16 Kg and 11.57 ± 10.12 months, respectively. Three patients (10%) required a
BIVAD implantation. After the implantation, 7 patients (23%) required re-intervention for
bleeding and 9 patients (30%) experienced BHE cannulas infection. A total of 56 BHE
pump were changed for thrombus formation (1.86 BHE pump for patient). The average
duration of VAD support was 132.8± 94.4 days. Twenty patients (67%) were successfully
transplanted and 10 patients (33%) died: 7 for major neurological complication and 3 for
sepsis.
Conclusion: Mechanical support in smaller children with end stage heart failure is an
effective strategy for bridging patients to HTx. The need for BIVAD was relegated, in the
last years, only to restrictive cardiomiopathy. Further efforts are required in small infants to
improve anticoagulation strategy to reduce neurological events and BHE pump changes.
Keywords: pediatric VAD, low weight LVAD, Berlin Heart
INTRODUCTION
The definitive treatment for the end stage pediatric heart failure is the orthotopic heart
transplantation (OHTx). However, because of the lack of organ donors, especially in very small
children, the use of ventricular assist device (VAD) is a validated therapy to bridge patients to
the OHTx with a success rate up to 84% (Ibrahim et al., 2000; Reinhartz et al., 2003; Chang and
McKenzie, 2005; Stiller et al., 2005; Hetzer et al., 2006; Gandhi et al., 2008; Brancaccio et al., 2010,
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2013; Potapov et al., 2011; Almond et al., 2013; Miera et al., 2014;
Kirklin, 2015; Mascio, 2015; Sandica et al., 2016).
The use of left VADs (LVAD) could successfully support
patients till the OHTx, increasing the cardiac output (CO),
unloading the left ventricle (LV) and decreasing the left atrial
pressure and the pulmonary arterial pressure. The LVADdecrease
the LV volumes and the LV work because of the flow distribution
between the native LV and the LVAD (Barbone et al., 2001). In
fact, in the presence of the LVAD, the total cardiac output is the
sum of the LV output and the LVAD output. Increasing the LVAD
cardiac output (increasing the LVAD speed in the continuous
flow LVAD or increasing the pump rate in pulsatility flow
LVAD) it is possible to obtain an increment of the total cardiac
output (untill a determined plateau) and a higher unloading
of the LV with lower LV volumes, lower left atrial pressure,
lower pulmonary pressure and lower LV output. In the case of
total support, all the cardiac output is totally provided by the
LVAD and the aortic valve remains closed. This condition is
usually avoided to permit to the LV at least a slight ejection
and to the aortic valve to open at least every three cardiac
cycle.
The effects of the LVAD on the right ventricular function is
controversial. In fact, one of the major complications in LVAD
patients is the right ventricular (RV) failure with an incidence
among 13–44% in adults and an incidence of 42% in children
(Chen et al., 1996; Kukucka et al., 2011; Saraiva Santos et al., 2012;
Karimova et al., 2014). Different explanations about the increased
risk of the RV failure in LVAD patients were proposed:
- RV work increase due to RV venous return increase thanks to
the LVADbecause the RV and the LVwork are in series. The RV
overload is proportional to the LVAD contribution (Mandarino
et al., 1992; Omoto et al., 2002),
- the leftward shift of the interventricular septum after the LVAD
implantation could decrease the support given by the septum to
the RV contraction and the leftward shift is proportional to the
LVAD contribution (Hendry et al., 1994; Omoto et al., 2002).
On the contrary, it has been considered that the LVAD could
decrease the RV afterload, decreasing the pulmonary arterial
pressure, possibly leading to a better RV pump functioning
(?). In literature, there are different opinions and several
authors performed also animal experiments to study the
interventricular interaction during LVAD assistance (Kawai et al.,
1992; Mandarino et al., 1992; Morita et al., 1992; Hendry et al.,
1994; Chen et al., 1996; Barbone et al., 2001; Omoto et al., 2002;
de Jonge et al., 2005; Kukucka et al., 2011; Saraiva Santos et al.,
2012; Umeki et al., 2012; Arakawa et al., 2014; Karimova et al.,
2014).
Di Molfetta et al. (2016) summarized with a simulation
the effects of the LVAD implantation and the effects of the
increased LVAD contribution using a lumped parameter
model (Figure 1). Increasing the LVAD contribution
a decrement of the LV preload and volumes and an
increment of the arterial systemic mean pressure can be
obtained together with an increment of the RV preload
and RV volumes and a decrement of the pulmonary mean
pressure. Finally, a decrement of the LV work and an
increment of RV work are obtained increasing the pump
contribution.
Analyzing the infant population, only the Berlin Heart
EXCOR (BHE; Berlin Heart, Berlin Heart AG, Berlin, Germany)
is licensed as long term VAD to bridge children to OHTx
(Ibrahim et al., 2000; Reinhartz et al., 2003; Chang andMcKenzie,
2005; Stiller et al., 2005; Hetzer et al., 2006; Gandhi et al., 2008;
Brancaccio et al., 2010, 2013; Potapov et al., 2011; Almond et al.,
2013; Miera et al., 2014). The smallest patients are particularly
demanding in terms of morbidity and mortality (Ibrahim et al.,
2000; Reinhartz et al., 2003; Chang and McKenzie, 2005; Stiller
et al., 2005; Hetzer et al., 2006; Gandhi et al., 2008; Brancaccio
et al., 2010, 2013; Potapov et al., 2011; Almond et al., 2013;
Miera et al., 2014) especially now that the LVAD staying is
increasing over time. In particular, small body surface area, BHE
size mismatch and younger age seems to be associated with an
increased risk of thromboembolic complications (Almond et al.,
2013; Miera et al., 2014).
In a recent study, Conway et al. reported about the outcome
of a multicenter study on 97 pediatric patients under 10 kg
undergoing Berlin Heart EXCOR VAD. In their study, the
median LVAD stay was 26 days with a survival to heart
transplantation less than 60% (Conway et al., 2015).
On the basis of these considerations, the aim of this study is to
retrospectively review our single-center experience on the use of
BHE in children under 10 Kg.
MATERIALS AND METHODS
Patients’ Data Collection
Data of all pediatric patients under 10 kg undergoing BHE
implantation in our institution from March 2002 to March 2016
were retrospectively reviewed including:
- Before the implantation: gender, diagnosis, age at the
implantation, weight at the implantation, previous surgery,
comorbidities, requirement of ECMO;
- During the implantation: concomitant surgical procedure,
requirement of biventricular assistance using two BHE,
neurological complication, bleeding, cannulas infections,
sepsis; BHE pump changes, length of VAD staying, clinical
outcome (OHTx, death, heart recovery, still on VAD), and
cause of death during the assistance;
Informed consent for the BHE implantation and the divulgation
of clinical data was obtained by all patients’ parents. The protocol
was approved by the ethical board of our hospital. The protocol
adheres to the principle expressed in the Declaration of Helsinki.
Surgical Procedure
All patients underwent BHE VAD implantation. The BHE
consists of a paracorporeal, pneumatically driven, polyurethane
blood pump with a multilayer flexible membrane separating
the blood from the air chamber. Silicon cannulae connect
the blood pump to the patient, and tri-leaflets inflow and
outflow valves prevent blood reflux. All surface in contact
with blood are heparin-coated. Each pump is driven by a
pulsatile electro-pneumatic system. All BHE implantation were
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FIGURE 1 | (A) RV (pra) and LV (pla) preload (mmHg), (B) RV (Pap) and LV (Pas) afterload (mmHg), (C) RV (RVV) and LV (LVV) average volumes (ml), (D) RV (RVEW)
and LV (LVEW) external work (J*100), (E) RV (Ep/Erv) and LV (Ea/Elv) ventriculo-arterial coupling as a function of LVAD rate.
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performed in a full median sternotomy and mild hypothermic
cardiopulmonary bypass. The heart was kept beating throughout
the procedure except in patients requiring the interatrial
communication closure where ventricular fibrillation was used.
Inflow cannulation for the left ventricular assist device (LVAD)
was preferentially achieved through the left ventricular apex
or, alternatively, through the left atrium (before 2007). The
pump size was chosen according to the BHE indications (Miera
et al., 2014). The VAD rate was set to assure an adequate
perfusion ranging from 100 ml/kg/min to 200 ml/kg/min. All
the other VAD parameters were set with the aim of assuring
a full-empty full-fill operating modality and with the aim of
assuring the aortic valve opening at least every three cardiac
cycle.
Anticoagulation Strategy and Patients
Monitoring
All patients were routinely evaluated performing one
echocardiography every week. Concerning the anticoagulation
strategy, in the first post-operative day, the unfractioned
heparin was started at initial dose of 15 IU/Kg/h every 12 h and
increased after 6 hours at therapeutic dose of 28 IU/Kg/h to
obtain a PTTs between 1.5 and 2.5 times the basal value with
a correspective anti Xa between 0.35 and 0.5. After 1 week, if
the active bleeding was absent, the hemodynamic status was
stable and renal function was normal, low molecular weight
heparin (LMWH) was introduced at a starting dose of 150 IU/kg
with a target anti Xa of 0.6–1.2 IU/ml. The anti-aggregation
therapy was modulated by platelet mapping, between 2nd and
4th POD if bleeding was stopped. Dypiridamole was started
at 1mg/kg/day at the POD 4 while the aspirin was started
at 1 mg/kg/day divided in 2 doses at the POD 7, when chest
drain are removed. Oral anticoagulant drugs (warfarin) was
considered in children older than 12 months when oral or enteral
feeding is optimized. Initial loading dose was 0.2mg/Kg/die
(maximum dose of 5 mg/die) and target INR was between 2.7
and 3.5.
Statistical Analysis
Continuous variables are expressed as mean values and standard
deviation or as median values, where appropiate. Survival
analysis is performed by Kaplan-Meyer curves and log rank test
(Mentel-Cox). Hazard ratio is estimated byMentel-Haenszel test.
Statistical analysis was performed using the commercial software
MedCalc.
RESULTS
Baseline Data
A total of 30 patients under 10 kg were implanted from 2002
to 2016 in our institution. Sixteen children were male (53%)
with a mean weight at the implantation of 6.75 ± 2.16 Kg
and an average age at the implantation of 11.57 ± 10.12
months. Most of the patients (25/30, 87%) were affected by a
dilated cardiomyopathy (secondary to myocarditis in 4 cases
and with left ventricular non compaction in 3 cases), 2 (6.5%)
patients were affected by a restrictive cardiomyopathy, 1 patient
developed heart failure post cardiotomy and 2 (6.5%) patients
had a failing univentricular heart physiology (Reinhartz et al.,
2003). Before the VAD implantation, one patient underwent
surgery for a supravalvular mitral ring and developed heart
failure post cardiotomy and two patients underwent Glenn
procedure. Before the BHE implantation, 8 patients (27%) were
mechanically ventilated and 3 patients (10%) were receiving
ECMO for cardiorespiratory failure (Table 1).
VAD Implantation
Inflow cannulation for the LVAD was achieved through the left
ventricular apex in the 27 (90%) children and through the left
atrium in three. From August 2007, left atrial cannulation was
dismissed in favor of left ventricular apical cannulation. An
isolated LVAD was used in 27 (90%) patients and a BiVAD in
three. All the BiVAD were implanted before 2007. Eight patients
(27%) underwent concomitant atrial septal defect closure, while
in one patient a ductus arteriosus was closed during the VAD
implantation.
Postoperative
Before 2007, two patients underwent percutaneous atrial septal
defect closure with an Amplatzer device after the LVAD
implantation for severe desaturation (Brancaccio et al., 2010).
Seven patients (23%) required re-intervention for bleeding after
the LVAD implantation and 9 patients (30%) experienced BHE
cannulas infection. A total of 56 BHE pumps were changed
along all the studied period for thrombus formation (1.86
BHE pumps for patient). Two LVAD patients underwent BHE
pump upgrading from 10ml to 15ml because of patients weight
increment after April 2013, when the 15 ml BHE became
available.
Outcome
The average duration of VAD support was 132.8 ± 94.4 days.
Then, 20 patients (67%) were successfully transplanted and 10
patients (33%) died. Of these 10 patients, 7 died for major
neurological complication and 3 for sepsis (Table 2).
TABLE 1 | Patients Demographics.
Variables Data
Male/Female 16/14
Age at implant [months] 11.57 ± 10.12
Weight [Kg] 6.75 ± 2.16
DIAGNOSIS
DCM 25 (83%)
RCM 2 (7%)
Failing UVH physiology 2 (7%)
After cardiotomy 1 (3%)
DCM, Dilatative Cardiomyopathy; RCM, Restrictive Cardiomyopathy; UVH, Univentricular
Heart; VAD, Ventricular Assist Device.
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TABLE 2 | Outcomes on VAD.
Outcome No. (%) Tot No 30 patients
Days of assistance 132.8 ± 94.4
OHTx 20 (67%)
Death on VAD 10 (33%)
Fatal neurological complications 7 (23%)
Fatal sepsis 3 (10%)
Cannulae infection 9 (30%)
Overall no of pump change 56 (1.86/pts)
Bleeding requiring surgery 7 (23%)
DISCUSSION
The use of BHE could successfully bridge pediatric patients
till the OHTx, but the management of small patients is
especially challenging. In fact, small body surface area seems
to be associated with an increased risk of thromboembolic
complications during VAD assistance and increased mortality
as reported by Almond et al. (2013). In accordance with this
consideration, Reinhartz et al. (2003) evidenced that an oversized
device, which is simpler in smaller patients, could lead to an
increased risk of thromboembolisms because of the stasis into
the devices or systemic hypertension due to large stroke work.
Similarly, Miera et al. (2014) demonstrated the influence of the
BHE size in relation to patients weight on the clinical outcome.
In fact, in their study Miera et al. evidenced that a large pump
size in relation to body surface area is an independent risk
factor for the occurrence of thromboembolic events (Miera et al.,
2014). Moreover, they evidenced that younger age and smaller
body surface area patients showed a trend of increased risk
of thromboembolic events. In their work, Stiller et al. (2005)
reported about the BHE implantation in 18 children less than
1 year underlying that the small children could be successfully
bridged to OHTx, but the intensive care management and the
anticoagulation strategy should be optimized to improve the
outcome in terms of mobility and mortality. Gandhi et al.
(2008) reported their experience on the use of BIVAD in 9
small children with an average weight of 9.4 kg (3 to 38 kg).
Patients were supported for 35 days (1 to 77) and then 8 patients
were successfully transplanted. It should be underlined that,
as reported by Hetzer et al. (Potapov et al., 2011), the length
of VAD staying is increasing over time and the management
of small patients to achive long term event free VAD support
is still challenging (Potapov et al., 2011). Finally, Conway et
al reported about the outcome of a multicenter study on 97
pediatric patients under 10 kg undergoing Berlin Heart EXCOR
VAD. In their study, the median LVAD stay was 26 days with a
survival to heart transplantation less than 60% (Conway et al.,
2015).
In our study, we reported our experience on the use of
BHE in 30 patients under 10 kg. Patients were assisted for
a median time of 132.8 ± 94.4 days that is a significantly
longer time compared to the experiences reported in literature
(Almond et al., 2013; Conway et al., 2015). Despite a longer
period of support the complications and the outcomes of
our population are comparable to the complications and the
outcomes reported in literature. Sixty seven percentage of
patients were successfully transplanted, 23% of patients required
re-intervention for bleeding, 23% of patients experienced major
neurological complication and 30% experienced BHE cannulas
infection.
In conclusion, the use of BHE in small children is becoming
of common use in recent years. Longer support time of several
months requires a careful management of these fragile patients
especially in terms of coagulation and infections. Good results
in short and long term are possible, encouraging the use of this
strategy as bridge to OHTx.
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